Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

January 30, 2013

Testosterone and its derivatives could constitute an efficient treatment against myelin diseases such as multiple sclerosis

  • MS Research Study and Reports
    /
  • Myelin Repair
    /
Androgenic hormones could help treat multiple sclerosis Paris- Testosterone and its derivatives could constitute an efficient treatment against myelin diseases such as multiple sclerosis, reveals a study…
MS Research Study and Reports

January 30, 2013

Do you take LDN or have taken LDN and want to share your story?

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
PO Box 1083, Buxton Norwich NR10 5WY Telephone: 0844 41 45 295 Email: contact@ldnresearchtrust.org Web: www.ldnresearhctrust.org www.ldnaware.org Contact: Linda Elesgood…
Alternative therapies and devices for Multiple Sclerosis (MS)

January 29, 2013

Quantitative MRIs evade multiple sclerosis clinicoradiologic paradox

  • MRI
    /
  • Multiple Sclerosis
    /
January 28, 2013 By Peter Sergo, medwireNews Reporter Quantitative magnetic resonance imaging (MRI) can detect microstructural changes in the spinal cords of…
MRI

January 29, 2013

Biogen says MS drug reduces relapse rates in study

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
Biogen says potential multiple sclerosis treatment reduces relapse rates in late-stage study Associated Press – Fri, Jan 25, 2013 WESTON, Mass. (AP)…
MS Drug Therapies

January 29, 2013

Genzyme: FDA will review Lemtrada, its drug candidate for relapsing MS

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
By Chris Reidy, Globe Staff Genzyme, now a Cambridge-based unit of French drug giant Sanofi SA., said Monday that the…
MS Drug Therapies

January 29, 2013

Sanofi Moves Closer to Multiple Sclerosis Drug Approval

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
By Brian Orelli |  January 28, 2013 |  Sanofi (NYSE: SNY  ) announced today that the Food and Drug Administration accepted its supplemental Biologics License Application requesting permission to…
MS Drug Therapies

January 28, 2013

Wintery weather + multiple sclerosis = difficult times

  • Additional MS resource sites
    /
  • An MS Patients Story
    /
  • Multiple Sclerosis
    /
Posted on 28 Jan 2013 at 12:10PM by ChefTrevis While frosted window panes, ice-tipped trees and snowy laneways may be…
Additional MS resource sites

January 28, 2013

The Art of Lost Connections

  • An MS Patients Story
    /
Written by Cathy Chester – of An Empowered Spirit January 27, 2013 Hello World Not returning phone calls?  Putting off…
An MS Patients Story

January 24, 2013

Biogen Sees Positive Results From Study of Potential Multiple Sclerosis Treatment

  • MS Drug Therapies
    /
By Dow Jones Business News,  January 24, 2013, By Saabira Chaudhuri Biogen Idec ( BIIB ) said data from a late-stage trial of…
MS Drug Therapies

January 24, 2013

Biogen’s injectable MS drug effective in trial

  • MS Drug Therapies
    /
January 24, 2012 (Reuters) – Biogen Idec Inc said on Thursday that a late-stage clinical trial of an experimental multiple…
MS Drug Therapies

Categories

Latest Blog Posts